Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a chinese han population

Molecular Carcinogenesis

Volumn 50, Issue 3, 2011, Pages 184-188

  Zhou, Yong ^a   Li, Ni ^a   Zhuang, Wen ^a   Wu, Xiaoting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gastric cancer; Gene polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79951846233     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20703     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
3. Devesa SS, Fraumeni JF, Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999; 91: 747-749.
4. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
5. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006; 580: 2879-2887.
6. Belinsky GS, Claffey KP, Nambiar PR, Guda K, Rosenberg DW. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Mol Carcinog 2005; 43: 65-74.
7. Iordache S, Saftoiu A, Georgescu CV, et al. Vascular endothelial growth factor expression and microvessel density-two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointestin Liver Dis 2010; 19: 135-139.
8. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996; 93: 1493-1495.
9. Bae SJ, Ahn DH, Hong SP, et al. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J 2008; 49: 783-791.
10. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235.
11. Lee SJ, Lee SY, Jeon HS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 571-575.
12. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008; 28: 1271-1276.
13. Dassoulas K, Gazouli M, Rizos S, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009; 48: 563-569.
14. Eroglu A, Ozturk A, Cam R, Akar N. Vascular endothelial growth factor gene 936C/T polymorphism in breast cancer patients. Med Oncol 2008; 25: 54-55.
15. Jacobs EJ, Feigelson HS, Bain EB, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006; 8: R22.
16. Krippl P, Langsenlehner U, Renner W, et al. A common 936C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-471.
17. Garcia-Closas M, Malats N, Real FX, et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007; 3: e29.
18. Tahara T, Shibata T, Nakamura M, et al. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog 2009; 48: 1030-1037.
19. Tahara T, Arisawa T, Shibata T, et al. Effect of polymorphisms in the 3'-untranslated region (3'-UTR) of VEGF gene on gastric pre-malignant condition. Anticancer Res 2009; 29: 485-489.
20. Guan X, Zhao H, Niu J, Tang D, Ajani JA, Wei Q. The VEGF-634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol 2009; 9: 77.
21. Guan X, Zhao H, Niu J, Tan D, Ajani JA, Wei Q. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res 2009; 28: 94.
22. Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms-A case-control study in an Omani population. Mol Carcinog 2009; 48: 1170-1176.
23. Ke Q, Liang J, Wang LN, et al. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 2008; 47: 647-651.
24. Kim JG, Sohn SK, Chae YS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007; 18: 1030-1036.
25. Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006; 94: 624-630.
26. Demetrick DJ. Re: Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival by Tzanakis N, Gazouli M, Rallis G. et al. J Surg Oncol 2006; 94: 549-550.
27. Chae YS, Kim JG, Sohn SK, et al. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 2006; 71: 266-272.
28. Bevan S, Houlston RS. Genetic predisposition to gastric cancer. Q J Med 1999; 92: 5-10.
29. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-829.
30. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260.
31. Lai KC, Chen WC, Tsai FJ, Li SY, Jeng LB. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer. Hepatogastroenterology 2005; 52: 944-948.
32. Loder N. Genetic variations can point the way to disease genes. Nature 1999; 401: 734.
33. Hofmann G, Langsenlehner U, Renner W, et al. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 2008; 134: 591-595.